Madison Avenue Partners, LP — 13F Holdings & Portfolio

CIK 1801265 · latest 13F-HR filed 2026-05-15

Madison Avenue Partners, LP manages $2.30B in 13F-reported U.S. long-equity assets across 27 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are SNDK (17.10%), GHC (11.30%), CPNG (7.69%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 7 new positions, exited 3, added to 4, and trimmed 14.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$2.30B

Long-equity book

Holdings

27

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+7 / −3 / ↑4 / ↓14

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • MAGNUM ICE CREAM CO NV$69.2M +67.9%
  • SANDISK CORP$52.8M +15.5%
  • STAGWELL INC$11.2M +28.6%
  • SINCLAIR INC$5.1M +37.0%
Show all 4

Top Trims

  • GLOBUS MED INC-$167.3M -73.0%
  • INDIVIOR PLC-$93.8M -41.6%
  • SOLVENTUM CORP-$35.0M -22.2%
  • MOLINA HEALTHCARE INC-$25.5M -23.2%
  • THERAVANCE BIOPHARMA INC-$23.6M -13.3%
Show all 14

New Positions

  • COUPANG INC$176.8M
  • ICON PLC$142.0M
  • APARTMENT INVT & MGMT CO$50.4M
  • STAAR SURGICAL CO$45.7M
  • PRIMO BRANDS CORPORATION$24.9M
Show all 7

Exited Positions

  • SOLSTICE ADVANCED MATLS INC$135.2M
  • UNIFIRST CORP MASS$58.6M
  • WORKIVA INC$5.2M
Show all 3
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 SANDISK CORP SNDK 80004C200 $393.3M 17.10% 619,010 SH
2 GRAHAM HLDGS CO GHC 384637104 $259.9M 11.30% 245,829 SH
3 COUPANG INC CPNG 22266T109 $176.8M 7.69% 9,363,621 SH
4 MAGNUM ICE CREAM CO NV MICC N5505D105 $171.1M 7.44% 11,445,529 SH
5 MARKEL GROUP INC MKL 570535104 $168.2M 7.32% 87,889 SH
6 THERAVANCE BIOPHARMA INC TBPH G8807B106 $154.4M 6.71% 9,511,150 SH
7 ICON PLC ICLR G4705A100 $142.0M 6.17% 1,282,838 SH
8 INDIVIOR PLC INDV 45579U109 $131.5M 5.72% 4,315,162 SH
9 SOLVENTUM CORP SOLV 83444M101 $122.5M 5.33% 1,875,736 SH
10 MOLINA HEALTHCARE INC MOH 60855R100 $84.5M 3.67% 633,877 SH
11 GALAPAGOS NV GLPG 36315X101 $74.0M 3.22% 2,465,179 SH
12 BRITISH AMERN TOB PLC BTI 110448107 $65.7M 2.86% 1,123,767 SH
13 GLOBUS MED INC GMED 379577208 $61.8M 2.69% 717,476 SH
14 STAGWELL INC STGW 85256A109 $50.4M 2.19% 8,014,322 SH
15 APARTMENT INVT & MGMT CO AIV 03748R747 $50.4M 2.19% 12,374,991 SH
16 STAAR SURGICAL CO STAA 852312305 $45.7M 1.99% 2,441,678 SH
17 WILEY JOHN & SONS INC WLY 968223206 $25.8M 1.12% 678,417 SH
18 PRIMO BRANDS CORPORATION PRMB 741623102 $24.9M 1.08% 1,321,942 SH
19 TURNING PT BRANDS INC TPB 90041L105 $21.5M 0.93% 247,723 SH
20 SINCLAIR INC SBGI 829242106 $19.1M 0.83% 1,473,484 SH
21 DNOW INC DNOW 67011P100 $16.3M 0.71% 1,365,067 SH
22 MAGNERA CORP MAGN 55939A107 $15.1M 0.66% 1,590,616 SH
23 CENTRAL BANCOMPANY CBC 152413100 $10.7M 0.46% 444,933 SH
24 KEROS THERAPEUTICS INC KROS 492327101 $6.9M 0.30% 626,583 SH
25 PAR TECHNOLOGY CORP PAR 698884103 $6.0M 0.26% 447,878 SH
26 FRANKLIN STR PPTYS CORP FSP 35471R106 $717.7K 0.03% 1,080,132 SH
27 SHARKNINJA INC SN G8068L108 $651.5K 0.03% 6,152 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $2.30B 27 0001801265-26-000003
2025-12-31 2026-02-17 $2.33B 23 0001801265-26-000002
2025-09-30 2025-11-14 $1.68B 20 0001801265-25-000008